Redx Pharma agrees to $425m all-share merger with Jounce Therapeutics
February 23, 2023Research and Development
UK-based clinical-stage biotech company Redx Pharma has agreed to a $425m all-share merger with US drug research business Jounce Therapeutics. …
AstraZeneca signs $63m agreement for gastric cancer treatment
February 23, 2023Medical Communications
AstraZeneca has announced that it has signed an exclusive license agreement (ELA) with KYM Biosciences Inc for CMG901, which is …
£1.6bn of research and development funding “surrendered” back to UK Treasury
February 23, 2023Medical Communications
A pot of £1.6bn which was originally allocated as the UK’s contribution to the €96bn Horizon Europe research funding programme …
OSE Immunotherapeutics Updates on Anti-IL-7 Receptor Antagonist OSE-127/S95011, a Breakthrough Approach in Chronic Inflammatory Autoimmune Diseases and Hematology
February 22, 2023Business Services
Nantes, France – February 22, 2023, 6:00 p.m.
Karyopharm and Menarini gain full MHRA approval for multiple myeloma drug
February 22, 2023Research and Development
Pharmaceutical companies Karyopharm Therapeutics and Menarini Group have announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) have …
FDA grants approval to Beckley Psytech’s short-acting psychedelic trial
February 22, 2023Research and Development
Beckley Psytech, a private, clinical-stage biotech company, announced that the FDA has granted Investigational New Drug (IND) approval for their …
PHARMANOVIA ENTERS IN-LICENSING AGREEMENT WITH AXSOME THERAPEUTICS TO MARKET AND FURTHER DEVELOP SUNOSI® (SOLRIAMFETOL), A FIRST-IN-CLASS TREATMENT FOR EXCESSIVE DAYTIME SLEEPINESS (EDS) IN PEOPLE WITH NARCOLEPSY AND OBSTRUCTIVE SLEEP APNOEA
February 22, 2023Business Services
BASILDON, UK, 22 February 2023 Pharmanovia, a global pharmaceutical company that revitalises, extends and expands the lifecycle of already …
Relation Therapeutics announces launch of flagship integrated wet–dry laboratory at the heart of London’s Knowledge Quarter
February 22, 2023Business Services
London, February 22, 2023 – Relation Therapeutics, a leader in the use of high-resolution biology, machine learning and clinical insights …
NICE Publishes Reimbursement Recommendation for Translarna™
February 22, 2023Business Services
London, UK, 22nd February, 2023 — PTC Therapeutics, Ltd. today announced the National Institute for Health and Care Excellence (NICE) has published …
Indegene launches Metaverse capabilities to help life sciences companies create immersive healthcare experiences
February 22, 2023Business Services
Princeton, United States / Bengaluru, India, February 21, 2023: Indegene, a digital-first, life sciences commercialization company today announced the launch …
Modus Therapeutics announces positive topline data from its Phase 1b LPS provocation study evaluating the potential of sevuparin for treatment of sepsis
February 22, 2023Business Services
STOCKHOLM, SWEDEN – 21 February 2023: Modus Therapeutics AB (“Modus”), a company developing innovative treatments for patients with major unmet …
FDA approval granted to BD’s HPV assay for use with ThinPrep Pap Test
February 22, 2023Medical Communications
Becton, Dickinson and Company (BD) has received FDA approval for its new HPV assay which will be used in testing …
Pfizer likely to be first to gain FDA approval for new RSV vaccine
February 22, 2023Research and Development
The FDA is expected to approve Pfizer’s new respiratory syncytial virus (RSV) vaccine this summer following its acceptance of the …
Beckley Psytech receives FDA Investigational New Drug (IND) approval for Phase IIb study of BPL-003, a novel synthetic formulation of 5-MeO-DMT (Mebufotenin)
February 21, 2023Business Services
Oxford, United Kingdom – 21 FEBRUARY 2023 – Beckley Psytech Ltd, a private, clinical-stage biotechnology company dedicated to addressing neuropsychiatric …
Unum UK expands employee digital health app
February 21, 2023Medical Communications
Employee benefits provider Unum UK has expanded its available modules on its Help@hand app, which aims to provide digital health …
CSL receives CMA from the European Commission for haemophilia B drug
February 21, 2023Medical Communications
CSL, a biotech company, has announced that it has received conditional marketing authorisation (CMA) from the European Commission (EC) for …
Hemab secures $135m in Series B funding for rare bleeding disorder treatment
February 21, 2023Research and Development
Hemab Therapeutics announced it received $135m from their oversubscribed Series B funding round. The funding will be used for their …
Scancell shares encouraging results from phase 1/2 cancer trial
February 21, 2023Research and Development
Scancell Holdings PLC have shared early results from its phase 1/2 cancer study which appear “very encouraging”, according to one …
AstraZeneca and MSD present final results of key secondary overall survival endpoint from Phase III PROpel trial at ASCO GU Cancers Symposium
February 20, 2023Business Services
Results from the final prespecified overall survival (OS) analysis of the PROpel Phase III trial in metastatic castration-resistant prostate cancer …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
